about
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trialKissing-loop interaction between 5' and 3' ends of tick-borne Langat virus genome 'bridges the gap' between mosquito- and tick-borne flaviviruses in mechanisms of viral RNA cyclization: applications for virus attenuation and vaccine developmentImmunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsGuiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccineDegrees of maturity: the complex structure and biology of flavivirusesVaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in MiceImmunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaquesActivity of T-1106 in a Hamster Model of Yellow Fever Virus InfectionE Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate VirulenceComparative Neuropathogenesis and Neurovirulence of Attenuated Flaviviruses in Nonhuman PrimatesInhibitory effect of essential oils obtained from plants grown in Colombia on yellow fever virus replication in vitroStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentNeuropathogenesis and Neurovirulence of Live Flaviviral Vaccines in MonkeysCellular Inflammatory Response to Flaviviruses in the Central Nervous System of a Primate HostA Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus InfectionPassage of Dengue Virus Type 4 Vaccine Candidates in Fetal Rhesus Lung Cells Selects Heparin-Sensitive Variants That Result in Loss of Infectivity and Immunogenicity in Rhesus MacaquesDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityT-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsStability of yellow fever virus under recombinatory pressure as compared with chikungunya virusSystems biology approach predicts immunogenicity of the yellow fever vaccine in humansMicroneedle-based vaccinesGlobal health security and the International Health Regulations.Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.Development of replication-competent viral vectors for HIV vaccine delivery.The niche reduction approach: an opportunity for optimal control of infectious diseases in low-income countries?The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.Yellow fever: a reemerging threat17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in miceCD8+ T cells complement antibodies in protecting against yellow fever virus.Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.Systems biology of vaccination for seasonal influenza in humans.Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelersDual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses.Infection of nonhost species dendritic cells in vitro with an attenuated myxoma virus induces gene expression that predicts its efficacy as a vaccine vectorYellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.Immunological features underlying viral hemorrhagic feversVaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
P2860
Q21092218-545B4936-FEBB-4AB1-8516-3786F3A96B3FQ24289179-D6B90E13-230B-4818-8B74-E8BA6080531BQ26777195-6E02474B-6886-4E38-BD92-5E6DF584B63BQ26782367-F9FB7611-B0B5-4DEE-98BE-F9763FE03BEEQ26824712-87397445-F165-492E-AE4C-8ED727A13BD8Q27303766-050ADA8E-3B2B-4295-9EE0-A82E42D2855AQ27319783-8AD3BC0B-A83D-40E3-BB1A-5DCB0F083FDAQ27480272-671615B9-DD61-4B83-A163-4919DA9B4C8CQ27486116-F31CFE57-D103-4FC7-9631-FFA45493B58BQ27486117-65E51EA7-D991-49E4-AD12-98CE194C3A55Q27488254-0C8ED4AF-0013-46F7-94ED-F13625AC034FQ27488364-C337BD3D-C641-45F7-B067-7974D8235D59Q27488399-4D15F1EB-B4B4-478A-A688-0ABD391B231FQ27489646-A87AE0E0-D811-4E60-8F5A-CCCB467658BEQ27489724-CD2AD02F-BEAD-497E-8392-4C5DBFAD80E0Q27489793-C05CE406-1CD2-454B-A4FD-432138A9F4ECQ27654848-85D08CDF-DAF8-4543-8AFB-627788FD98F7Q28485408-6BB9C515-629B-4B9E-BFF5-81E7CBAE4FBAQ28741831-F8E30096-03CE-46CE-B5B0-881B3F171E0CQ29616204-0DDCE88B-3C20-4CCE-B95D-3AEE2A512E46Q30380910-9F0C5EF2-56E8-4E9B-96ED-B46540FEF42CQ30397198-A14C47F5-9646-4BC4-8863-AB75D062A4DEQ33576050-9591D8CA-7BD0-4CC7-9FCC-2D483947DDA2Q33610555-35A2CDF3-519A-4F44-9279-FF83F0F15CCBQ33694226-3162525F-E27D-479A-972A-12726362AD0AQ34012110-04D287D8-C561-4758-B187-4A69D8CEB9B0Q34036778-3D4E26A3-E80C-4736-93C7-3E926AF9CDA9Q34118209-81F7448D-2B39-4D2A-AD93-7F423CDC4F25Q34515690-0A6D1D07-25C3-41D6-BA21-940224134FC5Q34529812-E536C34E-7EBC-46D2-B71E-B67D33371C86Q34615061-B9FEC377-170E-470C-8E71-1C9A50CC1CB8Q34980404-69058DA6-0CCC-46D5-BA4D-BFF5AFE1EA1FQ35046285-8305D761-6974-4193-B04E-27E75195973CQ35118722-929819C6-41FA-4157-AA70-7BFD6774D0F9Q35175842-2364EBCE-06F1-4BFE-8697-3E4A22D87C10Q35532741-809BD722-E4DB-4EC5-BFF8-5A76E7EE75E4Q35599411-B4103EB5-B384-466F-B69E-D2BA3BDDA493Q35814851-2C09BA23-8415-4340-9A7A-80CDAE6DB9D7Q36122433-CA2F5D0F-4E17-41AE-A3A9-BCBBE3879B6BQ36577153-0E1EAC2B-546A-4D3E-9E73-C2005B855054
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Yellow fever vaccine.
@ast
Yellow fever vaccine.
@en
type
label
Yellow fever vaccine.
@ast
Yellow fever vaccine.
@en
prefLabel
Yellow fever vaccine.
@ast
Yellow fever vaccine.
@en
P2860
P356
P1476
Yellow fever vaccine.
@en
P2860
P304
P356
10.1586/14760584.4.4.553
P577
2005-08-01T00:00:00Z